Loading stock data…
Medifast (MED)
$10.70+0.19 (+1.81%)
After Hours$10.70+0.00 (+0.00%)· Last close Jun 29
Medifast, Inc., through its subsidiaries, operates as a health and wellness company that provides habit-based and coach-guided lifestyle solutions to address weight loss in the United States.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Medifast, Inc. in the Consumer Cyclical sector is trading at $10.70 with a market capitalization of $130M. Wall Street consensus targets $12.00 (1 analysts), implying a +12.1% move over the next 12 months. The stock is currently 31% below its 52-week high of $15.46, remaining 7.9% below its 200-day moving average. On fundamentals, Piotroski 4/9 shows mixed financial quality, Altman Z in the safe zone. Risk note: RSI 25 is oversold, raising the odds of a near-term bounce; MACD remains below its signal line. The Whystock Score of 65/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Sell-side targets imply +12.1% upside over 12 months
Long-term trend bearish (price vs 200-day SMA)
Oversold momentum (RSI 25) — potential for technical mean-reversion
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $76.04M↑ | $75.10M↓ | $89.41M↓ | $105.56M↓ | $115.73M |
| Gross Profit | $51.76M↓ | $52.14M↓ | $62.16M↓ | $76.64M↓ | $84.25M |
| Operating Income | -$3.29M↑ | -$7.80M↓ | -$4.08M↓ | -$1.07M↑ | -$1.26M |
| Net Income | -$2.12M↑ | -$18.12M↓ | -$2.26M↓ | $2.48M↑ | -$772,000 |
Peer Comparison
AMZNTSLAHD
Fundamentals
Medifast, Inc., through its subsidiaries, operates as a health and wellness company that provides habit-based and coach-guided lifestyle solutions to address weight loss in the United States. The company offers weight loss, weight management, and hea...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$130.09M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-10.13%
Volume
Today's trading volume
181,387
Recent News
Brown-Forman's Brand Strength and Premiumization Efforts Fuel Growth
BF.B is driving growth through premiumization, innovation and emerging-market expansion while strengthening its premium spirits portfolio.
Newell's Productivity & Other Strategic Efforts Bolster Growth
NWL is boosting margins through productivity, pricing and organizational realignment while investing in innovation and operational efficiency.
Medifast (MED) Loses 18.9% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
The heavy selling pressure might have exhausted for Medifast (MED) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
Will Keurig's Brand Strength & Strategic Actions Power Growth?
KDP is fueling growth through coffee leadership, product innovation, premiumization and productivity while expanding into faster-growing beverage categories.
Archer Daniels' Innovation, Cost Discipline and Nutrition Aid Growth
ADM is advancing cost savings, innovation and digital initiatives while strengthening Nutrition and streamlining operations to support long-term growth.